HOTEL INFO: please call us to assist with your reservation

Sheraton Maui Resort & Spa $399 per night, single or double occupancy

https://kaanapaliresort.com › sheraton-maui-resort-spa

Dr. Stan Louie, Pharm D.

University of Southern California

Dr. Stan Louie received his Doctorate in Pharmacy from the University of California in San Francisco. He continued his postgraduate work at Pacific Presbyterian Medical Center in San Francisco where he was a pharmacy resident. In addition to clinical training, he continued his basic science training at the Kuzell Institute, where he served as Associate of Research in Molecular Biology. Following his training at Kuzell, he joined USC where he continued his work on cytokine regulation in relation to tumor and/or viral proliferation at the Kenneth Norris Cancer Research Institute. Presently, he is an Associate Professor at the University of Southern California School of Pharmacy and the Keck School of Medicine, where he is concentrating his work on virally-linked diseases, which include HIV and hepatitis B & C.  In addition, he continues his efforts in drug discovery and development for the treatment of specific brain cancers and multiple myeloma.

Friday July 11, 2025

UPDATES ON THE TREATMENT OF AUTOIMMUNE DISEASE 2025

ACPE# TBA

Objectives:

1.  Describe contributive factors to exacerbating autoimmune disease severity.
2.  Distinguish organ specific and systemic autoimmune disease where to focus pharmacotherapy.
3.  Explain immunologic mechanism(s) known that mediates disease progression.
4.  Describe pharmacologic approaches to mitigate co-morbidities and the disease modifying agents.
5.  Describe the common immunologic targets used to manage various types of autoimmunity (e.g. multiple sclerosis, rheumatoid arthritis, psoriasis, inflammatory bowel syndrome, and systemic lupus erythematosus).

Saturday July 12, 2025

CORONAVIRUS: WHAT WE KNOW ABOUT THE VIRUS

ACPE# TBA

Objectives:

1.  Describe the background to the origin and the evolution of coronaviruses.
2.  Compare the difference between the various types of coronaviruses.
3.  Demystify how the coronavirus and specifically SARS-CoV2 is transmitted.
4.  Understand how the virus infects the ACE2 positive cells.
5.  Describe the variants associated with SARS-CoV2.
6.  Understand the treatment strategies to battle SARS-CoV2: comparisons of vaccine strategies (RNA vs. DNA-based vaccines), immunopathology of COVID-19, immunomodulatory treatment, ARDS associated with SARS-CoV2, and treatment for ARDS.
7.  Review biomarkers suggestive of immune dysregulation.
8.  Summarize current evidence on use of corticosteroids.
9.  Identify new inflammatory biomarkers with potential clinical utility.